Matches in Wikidata for { <http://www.wikidata.org/entity/Q85013806> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q85013806 description "artículu científicu espublizáu en setiembre de 2012" @default.
- Q85013806 description "im September 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85013806 description "scientific article published on 19 September 2012" @default.
- Q85013806 description "wetenschappelijk artikel" @default.
- Q85013806 description "наукова стаття, опублікована у вересні 2012" @default.
- Q85013806 name "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin" @default.
- Q85013806 name "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin" @default.
- Q85013806 type Item @default.
- Q85013806 label "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin" @default.
- Q85013806 label "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin" @default.
- Q85013806 prefLabel "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin" @default.
- Q85013806 prefLabel "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin" @default.
- Q85013806 P1433 Q85013806-7592A74A-F235-4636-934E-F1B87AF9D135 @default.
- Q85013806 P1476 Q85013806-B931B43F-DD26-45B6-ACE6-2588AE086421 @default.
- Q85013806 P2093 Q85013806-087B3AD7-1D4E-4A98-A543-801EB59997CA @default.
- Q85013806 P2093 Q85013806-13A3894A-AFFB-45D0-B909-93D8D3FF4BAD @default.
- Q85013806 P2093 Q85013806-499AB637-0075-40CD-BE43-AB4F58BB3525 @default.
- Q85013806 P2093 Q85013806-5A5BF4CC-3E8F-47F3-9BBD-5C3A32370EB6 @default.
- Q85013806 P2093 Q85013806-A0B4B70B-352E-41D7-BA77-788A0A21EF82 @default.
- Q85013806 P2093 Q85013806-A425B04F-8E7C-40F2-B0CC-EF69184F95DF @default.
- Q85013806 P2093 Q85013806-BE3634B5-DF03-445B-BB5D-E4A8E2292436 @default.
- Q85013806 P2093 Q85013806-C5F4D4CC-2BE7-423C-83CE-A9A096F3512D @default.
- Q85013806 P304 Q85013806-FE6C41EE-648D-42D0-8454-A0A2140AB1FF @default.
- Q85013806 P31 Q85013806-BA255D43-5443-47B5-ADEF-B20BF72E62AA @default.
- Q85013806 P356 Q85013806-A23EBD90-AADA-4168-9610-4572D3A64BAA @default.
- Q85013806 P433 Q85013806-15CB7603-9050-44E1-B5A6-81D8FA481AA8 @default.
- Q85013806 P478 Q85013806-8084FBCC-C413-4A86-814F-6D48D9F7CBFC @default.
- Q85013806 P577 Q85013806-E90F5D47-D532-4E23-B210-4D1105AC83AD @default.
- Q85013806 P698 Q85013806-465E25F6-1CE3-426A-B5D2-BC02CFCF9793 @default.
- Q85013806 P356 J.JURO.2012.07.020 @default.
- Q85013806 P698 22998907 @default.
- Q85013806 P1433 Q15709979 @default.
- Q85013806 P1476 "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin" @default.
- Q85013806 P2093 "Celine Moore" @default.
- Q85013806 P2093 "Glen C MacDonald" @default.
- Q85013806 P2093 "Jacinthe Guindon" @default.
- Q85013806 P2093 "Jeannick Cizeau" @default.
- Q85013806 P2093 "Joycelyn Entwistle" @default.
- Q85013806 P2093 "Louise Brazas" @default.
- Q85013806 P2093 "Mark Kowalski" @default.
- Q85013806 P2093 "Michael A S Jewett" @default.
- Q85013806 P304 "1712-1718" @default.
- Q85013806 P31 Q13442814 @default.
- Q85013806 P356 "10.1016/J.JURO.2012.07.020" @default.
- Q85013806 P433 "5" @default.
- Q85013806 P478 "188" @default.
- Q85013806 P577 "2012-09-19T00:00:00Z" @default.
- Q85013806 P698 "22998907" @default.